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Abstract: Keratinocytes provide the first line of defense of the human body against carcinogenic
ultraviolet (UV) radiation. Acute and chronic UVB-mediated cellular responses were widely studied.
However, little is known about the role of mitochondrial regulation in UVB-induced DNA damage.
Here, we show that poly (ADP-ribose) polymerase 1 (PARP1) and ataxia-telangiectasia-mutated
(ATM) kinase, two tumor suppressors, are important regulators in mitochondrial alterations induced
by UVB. Our study demonstrates that PARP inhibition by ABT-888 upon UVB treatment exacerbated
cyclobutane pyrimidine dimers (CPD) accumulation, cell cycle block and cell death and reduced
cell proliferation in premalignant skin keratinocytes. Furthermore, in human keratinocytes UVB
enhanced oxidative phosphorylation (OXPHOS) and autophagy which were further induced upon
PARP inhibition. Immunoblot analysis showed that these cellular responses to PARP inhibition upon
UVB irradiation strongly alter the phosphorylation level of ATM, adenosine monophosphate-activated
kinase (AMPK), p53, protein kinase B (AKT), and mammalian target of rapamycin (mTOR) proteins.
Furthermore, chemical inhibition of ATM led to significant reduction in AMPK, p53, AKT, and mTOR
activation suggesting the central role of ATM in the UVB-mediated mitochondrial changes. Our
results suggest a possible link between UVB-induced DNA damage and metabolic adaptations of
mitochondria and reveal the OXPHOS-regulating role of autophagy which is dependent on key
metabolic and DNA damage regulators downstream of PARP1 and ATM.
Keywords: UVB; PARP; mitochondria; metabolism; biogenesis; autophagy; carcinogenesis;
DNA repair
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1. Introduction
Mitochondria regulate their shape, number, distribution, mass, content of mitochondrial DNA
(mtDNA), and metabolic capacity in a process called mitochondrial biogenesis, which requires
the orchestration of complex transcriptional control of both nuclear and mitochondrial genes [1,2].
The function of mitochondrial biogenesis is to provide quality control of mitochondria by regulating
mitochondrial fission, fusion, and mitophagy [3,4] to maximize the energy utilization of mitochondria [5]
to meet cellular and environmental demands. Imbalances or perturbations in these processes can lead
to mitochondrial dysfunction [3,6].
Accumulating evidence suggests that mitochondria also play a central role in skin physiology.
Although, involvement of other organ systems predominates in classical mitochondrial disorders,
several cutaneous diseases can be linked to mitochondrial dysfunctions [7]. Interestingly, mitochondria
lack functional nucleotide excision repair (NER) pathway [8,9] which is responsible for the removal of
ultraviolet (UV)-induced DNA lesions including cyclobutane pyrimidine dimers (CPD). Accumulation
of these DNA photoproducts in mtDNA leads to mutations and deletions resulting in mitochondrial
alterations which have been associated with photoaging [10,11] and are present in melanoma [12],
as well as in non-melanoma skin cancers [13,14]. The other types of mitochondrial alterations such
as upregulated oxidative phosphorylation (OXPHOS), mitochondrial membrane hyperpolarization,
and decreased mitophagy are frequently observed in patients with DNA repair deficiencies [15–18].
Even though, these DNA repair proteins are encoded by the nuclear genome, their absence lead
to mitochondrial functional changes emphasizing the importance of nucleus-to-mitochondria (NM)
signaling [19].
Growing evidence suggests that the key component of NM signaling is poly (ADP-ribose)
polymerase 1 (PARP1) activation [19,20]. PARP1 is a multifunctional zinc-finger protein involved in the
regulation of DNA repair, chromatin structure, cell cycle, calcium homeostasis, transcription regulation,
cell death, immune response, and metabolism [21,22]. Through either direct interaction or via poly
(ADP-ribose) (PAR) polymer formation PARP1 can modulate the activity of ataxia-telangiectasia
mutated kinase (ATM) [23] and tumor suppressor protein 53 (p53) [24,25] involved in DNA damage
response. Enhanced PARP1 activity also induces ATP depletion [26], which implies the activation of
AMPK-activated protein kinase (AMPK) [27,28] that is responsible for the regulation of various cellular
pathways including protein kinase B (AKT) and mammalian target of rapamycin (mTOR) [29–31].
This complex interplay between PARP1, ATM, AMKP, p53, AKT, and mTOR indicates that these
DNA damage responders can fine-tune and modulate the interaction between DNA repair pathways
with metabolism [32]. PARP1 and PARP2 also modulate mitochondrial activity through NAD+
depletion [33–35]. Pharmacological inhibition or deletion of PARP1 and PARP2 improves mitochondrial
function and protects against mitochondrial [36,37], metabolic [34], and neurological diseases [38].
PARP inhibitors became valuable tools in treating cancer cells harboring DNA repair defect with the
combination of either radio- or chemotherapy [39–41]. In addition to several orally-administered
PARP inhibitors that are under active clinical development, recently ABT-888 (veliparib) has emerged
as an effective drug in treating various solid tumors [42] partially via modulating mitochondrial
activity [43,44].
Although UV radiation has been shown to trigger morphological [45,46] and functional changes
of mitochondria [47–49], published data led to contradictory results most likely due to the diversity of
applied UV spectrum, UV dose, and cell type. Studies using UVC irradiation revealed that UVC induced
mitochondrial hyperfusion and resulted in enhanced ATP synthesis via oxidative phosphorylation
(OXPHOS) [50]. Other authors demonstrated that UVC irradiation caused a significant increase in
mitochondrial content, oxygen consumption, and fatty acid oxidation [28]. Nevertheless, the functional
consequences of mitochondrial alterations after UVB-induced DNA damage and the molecular
pathways leading to mitochondrial changes remain to be elucidated.
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In this study, we defined the central role of PARP1 and the linked molecular pathways in
mediating UVB-induced DNA damage response and mitochondrial changes in a clinically relevant
human keratinocyte cell line.
2. Results
2.1. PARP Inhibition Impairs CPD Repair, Augments UVB-Induced Cell Cycle Block, Apoptosis and Reduces
Keratinocyte Proliferation
To explore the effect of UVB on PARP activation, firstly, we investigated poly (ADP-ribose)
polymer (PAR) formation in a time-dependent manner in human immortalized keratinocytes exposed
to mid (20 mJ/cm2) or high (40 mJ/cm2) dose of UVB (Figure 1A). In HaCaT cells, poly (ADP-ribosyl)
ation (PARylation) signal was initially observed at and over 95 kDa at 5 min after UVB exposure and
the extent of PARP activation was dose-dependent with higher PARP activation after 40 mJ/cm2 UVB
exposure. The signal was lost when cells were treated with ABT-888, a pan-PARP inhibitor (for uncut
PAR western see Supplementary Figure S2). PARP1 is considered to contribute 85–90% to total PARP
activity, the rest is largely the activity of PARP2 [51–53]. Moreover, the size of the PARylated band
suggests PARP1 (auto) PARylation indicating the involvement of PARP1 in UVB-induced damage.
Since PARP1 is involved in regulation of various DNA repair pathways, we wanted to assess how PARP
inhibition (PARPi) regulates the removal of cyclobutane pyrimidine dimers (CPDs) introduced by UVB
(Figure 1B). A slow decline of CPDs after UVB exposure was observed, reflective of nucleotide excision
repair (NER) activity. In contrast, the relative amount of CPDs in PARP-inhibited cells remained
elevated even after 24 h compared to the UVB-irradiated cells suggesting impaired efficiency of NER,
similarly as described by King et al. [54]. Since unrepaired photolesions can initiate cell cycle block to
prevent cells with DNA damage from entering mitosis, we performed cell cycle analysis (Figure 1C,D).
A higher proportion of PARP-inhibited cells after 20 mJ/cm2 UVB accumulated in G2/M phase of cell
cycle characteristic of enhanced DNA damage [21]. ABT-888 treatment sensitized cells to apoptosis
after UVB as reflected by decreased cell viability 24 h post-UVB compared to controls (Figure 1E). Gene
silencing of PARP1 showed similar changes regarding cell viability as PARP inhibition. Furthermore,
long-term keratinocyte survival using May-Grünwald-Giemsa staining in clonogenic assay showed that
ABT-888 treatment led to a marked decrease in the number of keratinocyte clones after UVB-irradiation
(Figure 2A,B). To find out whether PARPi-induced retention of CPDs induce higher mutation rate, we
performed hypoxanthine-guanine phosphoribosyltransferase (HPRT) mutation assay (Figure 2C,D).
We could not adjust the method for HaCaT keratinocytes as these cells were extremely tolerant to
the 6-thioguanine selection medium. Therefore, we used Chinese hamster ovary (CHO) cells which
is a widely used cell line for HPRT mutation assay [55–57] and also show high level of p53 protein
level due to p53 mutation [58,59] as HaCaT cells do [60]. In this case, we used lower UVB doses to
allow the accumulation of mutations compared to higher UVB which potentially triggers apoptosis.
Although, both 10 and 20 mJ UVB resulted in increased number of HPRT-mutated cells, interestingly
PARP inhibition caused a marked reduction in the number of mutated cell colonies suggesting that
PARPi initiate apoptosis of cells with high CPD content instead of allowing the accumulation of
gene mutations. Interestingly, some DNA damage markers, including cell viability, CPD and colony
formation, cell cycle progression showed no significant difference between the vehicle and ABT-888
treated groups after 40 mJ/cm2. This phenomenon can be due to the fact that 40 mJ/cm2 UVB dose in
our experiments represents such high DNA damage that cannot be augmented by PARP inhibition.
However, PARP1 knockdown cells displayed significantly lower cell viability compared to control
siRNA-transfected cells even after 40 mJ/cm2 UVB irradiation.
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Figure 1. Poly (ADP-ribose) polymerase (PARP) inhibition impairs cyclobutane pyrimidine dimer 
(CPD) repair, augments ultraviolet B (UVB)-induced cell cycle block and apoptosis. (A) Time-course 
of PARP activity (PAR) after 20 and 40 mJ/cm2 UVB exposure and 25 µM ABT-888 were analyzed by 
Western blot (n = 3). (B) Cells were exposed to a single dose of 20 or 40 mJ/cm2 UVB and collected at 
various time points for DNA extraction. CPD formation was determined by ELISA (n = 4). (C,D) Cell 
cycle progression was evaluated by propidium iodide staining after 24 h. DNA content was analyzed 
in FL2-A (n = 4). (E) Cell viability, apoptosis, and necrosis was assessed by dual labelling with Annexin 
V-Alexa 488 and propidium iodide 24 h post-UVB. Double negative cells are considered as viable (n 
= 5). (F) Cell viability was measured similarly as in Figure 1E after PARP1 knockdown (n = 3). −/+ 
represent vehicle (−) or ABT-888 (+) treatment *; ** and *** indicate statistically significant difference 
at p < 0.05 and p < 0.01, p < 0.001, respectively. Error bars represent SEM. 
Figure 1. Poly (ADP-ribose) polymerase (PARP) inhibition impairs cyclobutane pyrimidine dimer
(CPD) repair, augments ultraviolet B (UVB)-induced cell cycle block and apoptosis. (A) Time-course
of PARP activity (PAR) after 20 and 40 mJ/cm2 UVB exposure and 25 µM ABT-888 were analyzed by
Western blot (n = 3). (B) Cells were exposed to a single dose of 20 or 40 mJ/cm2 UVB and collected at
various time points for DNA extraction. CPD formation was determined by ELISA (n = 4). (C,D) Cell
cycle progression was evaluated by propidium iodide staining after 24 h. DNA content was analyzed
in FL2-A (n = 4). (E) Cell viability, apoptosis, and necrosis was assessed by dual labelling with Annexin
V-Alexa 488 and propidium iodide 24 h post-UVB. Double negative cells are considered as viable
(n = 5). (F) Cell viability was easured si ilarly as in Figure 1E after PARP1 knockdown (n = 3). −/+
represent vehicle (−) or ABT-888 (+) treatment *; ** and *** indicate statistically significant difference at
p < 0.05 and p < 0.01, p < 0.001, respectively. Error bars represent SEM.
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Figure 2. Poly (ADP-ribose) polymerase (PARP) inhibition decreases clone formation and ultraviolet 
B (UVB)-induced mutation rate. (A,B) Colony formation assay of HaCaT cells after 10 days post-UVB 
exposure was assessed by clonogenic assay (n = 4). (C,D) HPRT mutation assay was carried out on 
CHO cells. Preselected hypoxanthine-guanine phosphoribosyltransferase (HPRT) mutant cells were 
cultured for 10 days post-UVB (n = 3). −/+ represent vehicle (−) or ABT-888 (+) treatment * and *** 
indicate statistically significant difference at p < 0.05 and p < 0.001, respectively. Error bars represent 
SEM. 
2.2. PARP Inhibition Enhances UVB-Mediated Mitochondrial Biogenesis 
Mitochondrial biogenesis, by promoting the growth, formation, and assembly of newly 
synthesized mitochondria, has recently been linked to cancer development [61], apoptosis [62–64], 
and DNA damage [18,28,65]. Accumulating evidence suggest that DNA damage can initiate 
mitochondrial biogenesis which is accompanied by elevation in mitochondrial number, area, and 
mass [18,28,65,66]. Transmission electron microscopic images revealed that UVB-treated cells contain 
more and longer cristae than non-irradiated cells (Figure 3A). This morphological alteration became 
more pronounced after PARP inhibition. Similarly, UVB treatment increased both mitochondria 
number and total mitochondrial area (Figure 3B,C). ABT-888 treatment resulted in further increase 
in these parameters suggesting that PARP inhibition may boost UVB-mediated mitochondrial 
response. Since mitochondrial content changes with the balance between mitochondrial biogenesis 
and turnover, we quantified mitochondrially encoded cytochrome C oxidase I (MTCO1)/succinate 
dehydrogenase complex, subunit A (SDHA) ratio that is a marker of mitochondrial biogenesis. This 
experiment demonstrated that the mitochondrially-encoded MTCO1 show strong induction after 
UVB irradiation and become even more expressed after PARPi, while the expression of the nuclearly-
encoded SDHA protein is unaltered (Figure 3D,E). The higher mitochondrial mass after both UVB 
and PARPi (Figure 3F) and the enhanced expression of the master regulators of mitochondrial 
biogenesis including mitochondrial transcription factor A (TFAM), nuclear respiratory factor 2 
(NRF2), and estrogen-related receptor alpha (ERRA) (Figure 3G) also suggest that PARPi augments 
the UVB-triggered mitochondrial biogenesis. 
Figure 2. Poly (ADP-ribose) polymerase (PARP) inhibition decreases clone formation and ultraviolet B
(UVB)-induced mutation rate. (A,B) Colony formation assay of HaCaT cells after 10 days post-UVB
exposure was assessed by clonogenic assay (n = 4). (C,D) HPRT mutation assay was carried out on CHO
cells. Preselected hypoxanthine-guanine phosphoribosyltransferase (HPRT) mutant cells were cultured
for 10 days post-UVB (n = 3). −/+ represent vehicle (−) or ABT-888 (+) treatment * and *** indicate
statistically significant difference at p < 0.05 and p < 0.001, respectively. Error bars represent SEM.
2.2. PARP Inhibition Enhances UVB-Mediated Mitochondrial Biogenesis
Mitochondrial biogenesis, by promoting the growth, formation, and assembly of newly synthesized
mitochondria, has recently b en linked to cancer development [61], apoptosis [62–64], and DNA
damage [18,28,65]. Accumulating evidence suggest that DNA damage can initiate mitochondrial
biogenesis which is accompanied by elevation in mitochondrial number, area, and mass [18,28,65,66].
Transmission electr n microscopic im ges reveal that UVB-treated cells contain more and longer
crist e than non-irradiated cells (Figure 3A). This m rphological alt ration became more pronounced
after PARP inhibition. Similarly, UVB treatment increased both mitochondria number and tot l
mitochondrial area (Figure 3B,C). ABT-888 treat ent resulted in further increase in these parameters
suggesting that PARP inhibition m y boost UVB-mediated mitochondrial response. Since mitochondrial
content changes with the balance between mitochondrial biogenesi and turnover, we quantified
mitoch drially encoded cytochrome C oxidase I (MTCO1)/succinat d hydrogenase c mplex, subu it
A (SDHA) ratio that is marker of mitochondrial biogenesis. This xperiment demonstrated that
the mitochondrially-encoded MTCO1 show strong induction after UVB irradiation and become even
more xpressed after PARPi, w ile t expression of the nu learly-encoded SDHA protein is naltered
(Figure 3D,E). The higher mitochondrial mass after both UVB and PARPi (Figure 3F) and the nhanced
expression of the master regulators of mitochondrial biogenesis including mitochondrial transcription
factor A (TFAM), nuclear respiratory factor 2 (NRF2), a d estrogen-related receptor alpha (ERRA)
(Figure 3G) also s ggest that PARPi augme ts the UVB-triggered mitocho drial biogenesis.
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Figure 3. Poly (ADP-ribose) polymerase (PARP) inhibition enhances ultraviolet B (UVB)-mediated 
mitochondrial biogenesis. (A) Effect of UVB irradiation and PARP inhibition on mitochondrial 
ultrastructure visualized by transmission electron microscopy (TEM) 24 h after UVB exposure. 
Enlarged pictures are displayed at the right bottom corner. Scale bar is presented on the lower panels. 
(B) Mitochondrial number and (C) area were calculated from TEM images (minimum 7 cells were 
analyzed). (D,E) Mitochondrial biogenesis was quantified by the ratio of the mitochondrially encoded 
cytochrome C oxidase I (MTCO1) and succinate dehydrogenase complex, subunit A (SDHA) 
expression 24 h post UVB (n = 3). (F) Mitochondrial mass was determined by Mitotracker Green 
labeling 24 h after UVB irradiation (n = 3). (G) mRNA levels of master regulators of mitochondrial 
biogenesis were quantified by real-time PCR 24 h post-UVB (n = min. 3). −/+ represent vehicle (−) or 
ABT-888 (+) treatment. *; ** and *** indicate statistically significant difference at p < 0.05 and p < 0.01, 
p < 0.001, respectively. Error bars represent SEM. 
Figure 3. Poly (ADP-ribose) polymerase (PARP) inhibition enhances ultraviolet B (UVB)-mediated
mitochondrial biogenesis. (A) Effect of UVB irradiation and PARP inhibition on mitochondrial
ultrastructure visualized by transmission electron microscopy (TEM) 24 h after UVB exposure. Enlarged
pictures are displayed at the right bottom corner. Scale bar is presented on the lower panels. (B)
Mitochondrial number and (C) area were calculated from TEM images (minimum 7 cells were analyzed).
(D,E) Mitochondrial biogenesis was quantified by the ratio of the mitochondrially encoded cytochrome
C oxidase I (MTCO1) and succinate dehydrogenase complex, subunit A (SDHA) expression 24 h post
UVB (n = 3). (F) Mitochondrial m ss was determined by Mitotracker Gr en labeling 24 h after UVB
irradiati n ( = 3). (G) mRNA levels of master regulat rs of mitocho drial biogenesis w re quantified
by real-time PCR 24 h post-UVB (n = min. 3). −/+ represent vehicle (−) or ABT-888 (+) treatment. *; **
and *** indicate statistically significant difference at p < 0.05 and p < 0.01, p < 0.001, respectively. Error
bars represent SEM.
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2.3. PARP Inhibition Augments UVB-Mediated Mitochondrial Fusion
To identify if UVB and PARPi also alters mitochondrial dynamics, we evaluated mitochondrial
morphology using confocal microscopy. Non-irradiated cells mainly contained fragmented
mitochondria which normally represents low metabolic activity. After 40 mJ/cm2 UVB, a statistically
significant reduction in the frequency of fragmented mitochondria and an elevation in tubular
mitochondria was detected compared to the non-irradiated control. The frequency of intermediate
mitochondria was increased after PARPi at 0 mJ UVB compared to the vehicle control, and we
also observed decreased fragmented mitochondrial frequency and higher percentage of tubular
mitochondria after 20 mJ/cm2 + ABT-888 treatment compared to the 20 mJ/cm2 UVB exposed cells
(Figure 4A). The dose-dependent effect of UVB in the branching aspect of mitochondria (Figure 4C) as
defined by form factor ((Perimeter2/(4pi × area)) was also observed suggesting enhanced mitochondrial
fusion after UVB and PARP inhibition. Finally, to confirm that the observed mitochondrial fusion are
regulated by the dynamin-related proteins, we checked the expression of mitofusin-1 (Mfn1), mitofusin-2
(Mfn2), and optic atrophy 1 (OPA1) (Figure 4D,E). Similarly to mitochondrial morphological alterations,
we detected enhanced protein expression of Mfn1, Mfn2, and OPA1 which support mitochondrial fusion
at the outer and inner mitochondrial membrane. These results clearly indicate that besides enhancing
mitochondrial biogenesis, UVB also triggers mitochondrial fusion and increases the complexity of
mitochondrial network which is more prominent after PARP inhibition.
2.4. PARP Inhibition and UVB Induces Bulk Autophagy but Not Mitophagy
Several DNA-damaging agents were shown to initiate autophagy [67,68] and mitophagy [69]
to remove damaged macromolecules or organelles including mitochondria, which prompted us
to explore if UVB and PARPi-induced mitochondrial biogenesis and morphological changes of
mitochondria affects autophagy or mitophagy. We used dual labelling of Mitotracker CMxROS to
stain mitochondria and microtubule-associated proteins 1A/1B light chain 3B (LC3A/B) antibody
to detect autophagosomes. Our results show the accumulation of LC3-positive cells after UVB
exposure. PARP inhibition augmented autophagy not only in UVB-exposed cells, but also under
non-irradiated conditions (Figure 5A,B). LC3B western blotting (Figure 5C) also confirmed these
results indicating the autophagy inducer role of ABT-888. PARP1 knockdown also showed similar
results but with much more pronounced autophagy induction after UVB (Figure 5E). Interestingly,
the role of PARP1 in the regulation of autophagy is controversial. Both autophagy inductor [70–72]
and inhibitor [73–75] role of PARP1 has been described suggesting that the autophagy-modulatory
effect of PARylation might show DNA damage and cell type specificity. Even though, we detected an
increased number of LC3 puncta, this type of macroautophagy cannot be considered as mitophagy
since autophagic puncta show very mild colocalization with mitochondria (Figure 5D). Furthermore, a
dose-dependent mitochondrial elongation was observed after UVB and PARP inhibition in Figure 4A,B
indicating mitochondrial fusion. Since fused mitochondria are protected from mitophagy [76], and
mitophagy-coupled elimination of mitochondria is usually preceded by fission [69] and decline in
mitochondrial function [77], the here experienced induction in autophagy is considered as general
autophagy and suggest that mitochondrial morphological rearrangements induced by UVB and PARPi
may interfere with the initiation of mitophagy.
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Figure 4. Poly (ADP-ribose) polymerase (PARP) inhibition augments ultraviolet B (UVB)-mediated 
mitochondrial fusion. (A) Effect of UVB irradiation and PARP inhibition on mitochondrial 
morphological subtypes (tubular, intermediate, and fragmented) are quantified based on confocal 
microscopic images 24 h post-UVB (minimum 29 cells). (B) Mitochondrial morphology visualized by 
confocal microscopy with Mitotracker Red CMXRos dye (n = 3). Enlarged pictures are displayed at 
the right bottom corner. Scale bar is presented on the images. (C) The branching aspect of 
Figure 4. Poly (ADP-ribose) polymerase (PARP) inhibition augments ultraviolet B (UVB)-mediated
mitochondrial fusion. (A) Effect of UVB irradiation and PARP inhibition on mitochondrial morphological
subtypes (tubular, intermediate, and fragmented) are quantified based on confocal microscopic images
24 h post-UVB (minimum 29 cells). (B) Mitochondrial morphology visualized by confocal microscopy
with Mitotracker Red CMXRos dye (n = 3). Enlarged pictures r display d at the right bottom corner.
Scale bar is presented on the images. (C) The branching aspect of mitochondria was derived from
confocal microscopic images and was represented as a form factor (n = 3). (D) Protein expression of
mitofusin-1 (Mfn1), mitofusin-2 (Mfn2), and optic atrophy 1 (OPA1) was visualized by Western blot.
(E) Expression of mitochondrial fusion proteins were analyzed by Western blot 24 h post-UVB (n =
min. 3). −/+ represent vehicle (−) or ABT-888 (+) treatment. *; ** and *** indicate statistically significant
difference at p < 0.05 and p < 0.01, p < 0.001, respectively. Error bars represent SEM.
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3B (LC3A/B) protein marker of autophagy by confocal microcopy (n = 3). Scale bar is presented on the 
figure. (B) Quantification of LC3A/B puncta in cells derived from confocal images in Figure 5A (n = 
3). (C) LC3A/B proteins were quantified by Western blotting. Brightness and contrast were adjusted. 
Protein of interest were normalized to the loading control B-actin. (D) Dual staining of LC3-puncta 
and mitochondria by confocal microscopy (n = 3). (E) Quantification of LC3A/B puncta in PARP1 
siRNA and control siRNA-transfected cells derived from confocal images (n = 4) −/+ represent vehicle 
(−) or ABT-888 (+) treatment *; ** and *** indicate statistically significant difference at p < 0.05 and p < 
0.01, p < 0.001, respectively. Error bars represent SEM. 
Figure 5. Poly (ADP-ribose) polymeras ( ) inhibition and ultraviolet B (UVB) induces bulk
autophagy but not mitophagy. (A) Expression of microtubule-associated proteins 1A/1B light chain 3B
(LC3A/B) protein marker of autophagy by confocal microcopy (n = 3). Scale bar is presented on the
figure. (B) Quantification of LC3A/B puncta in cells derived from confocal images in Figure 5A (n = 3).
(C) LC3A/B proteins were quantified by Western blotting. Brightness and contrast were adjusted.
Protein of interest were normalized to the loading control B-actin. (D) Dual staining of LC3-puncta and
mitochondria by confocal microscopy (n = 3). (E) Quantification of LC3A/B puncta in PARP1 siRNA
and control siRNA-transfected cells derived from confocal images (n = 4) −/+ represent vehicle (−) or
ABT-888 (+) treatment *; ** and *** indicate statistically significant difference at p < 0.05, p < 0.01 and
p < 0.001, respectively. Error bars represent SEM.
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2.5. PARP Inhibition Boosts UVB-Mediated Mitochondrial Bioenergetic Changes
Alterations in the mitochondrial network is strictly controlled by intra- or extracellular signals
connecting mitochondrial biogenesis and fusion with energy perturbations. To test whether
increased mitochondrial biogenesis and fusion after UVB and PARP inhibition supports mitochondrial
activity, we evaluated mitochondrial parameters. Our results show that UVB exposure increased
mitochondrial membrane potential (Figure 6A) and total ATP level (Figure 6B). PARPi boosted the
UVB-induced mitochondrial membrane hyperpolarization and it also raised ATP level compared to
UVB-irradiated samples. Mitochondrial membrane potential and ATP levels change independently,
and hyperpolarization of mitochondrial membrane potential does not necessarily correlate with ATP
production but it may stem from decreased F0F1 ATP synthase activity and concomitant lower ATP
production. Furthermore, increased ATP level may result either from enhanced glycolysis, increased
respiration via electron flow from complex I-V, or decreased energy expenditure. In order to clarify
the reasons of the elevation in ATP levels, we complemented our data with quantitative analysis of
metabolic flux by XF96 oximeter and monitored extracellular acidification rate (ECAR) indicating
glycolysis and oxygen consumption (OCR) representing oxidative phosphorylation with sequential
addition of oligomycin and antimycin. Although basal ECAR (Figure 6C) is statistically unchanged
after UVB exposure, PARP inhibition enhanced the rate of glycolysis after 20 mJ/cm2 UVB dose and at
non-irradiated conditions. In contrast, UVB dose-dependently increased oxygen consumption and
ABT-888 treatment significantly augmented OXPHOS compared to 0 or 20 mJ/cm2 UVB (Figure 6C).
Citrate synthase (CS) activity, the initial enzyme in the tricarboxylic acid (TCA) cycle catalyzing the
formation of citrate from oxalacetate and acetyl-CoA, showed significant elevation after UVB radiation,
which was augmented by PARP inhibition (Figure 6C). This suggest that not only the distal part of
respiratory chain is altered by UVB and PARPi, but also increased terminal oxidation is preceded by
elevation in TCA activity as well. To exclude the possibility of the off-target effects of ABT-888, we
confirmed the mitochondrial changes by PARP1 silencing. We detected increased mitochondrial mass
reflecting mitochondrial biogenesis after UVB in control siRNA-transfected keratinocytes that was
elevated by PARP1 knockdown (Figure 6D). Mitotracker Red CMXRos incorporation into mitochondria
reflecting mitochondrial membrane potential also showed similar changes similarly after vehicle and
ABT-888 treatment (Figure 6E). Although, we could not detect difference in basal ECAR between
the control and PARP siRNA-transfected cells, CS activity and OXPHOS showed significant changes
(Figure 6F) confirming the pivotal role of PARP1 in the UVB-induced mitochondrial changes. In
summary, we can conclude that elevation in cellular ATP level after UVB is due to enhanced energy
production and cells increase their energy reserves through both glycolysis, TCA cycle, and OXPHOS
after PARP inhibition.
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Figure 6. PARP inhibition boosts UVB-mediated mitochondrial bioenergetic changes. (A) For 
determination of mitochondrial membrane potential cells were stained with 3,3′-
dihexyloxacarbocyanine iodide (DIOC6(3)) 24 h post-UVB and measured by flow cytometry in FL1 
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of mitochondrial membrane potential cells were stained with 3,3′-dihexyloxacarbocyanine iodide
(DIOC6(3)) 24 h post-UVB and measured by flow cytometry in FL1 channel (n = 4). (B) Total cellular
ATP level was quantified by colorimetric assay (n = 3). (C) Basal extracellular acidification rate (ECAR)
represents glycolysis after 24 h post-UVB. XF medium was supplemented with 10 mM glucose (n = 6).
After four oxygen consumption rate (OCR) measurement oligomycin and antimycin was used to determine
mitochondria-linked ATP production and basal OCR, r spectively (n = 6). Citrate synthase activity, the
initial enzyme of the tricarboxylic acid (TCA) cycle was measured by citrate synthase kit (n = 3). (D)
Mitochondrial mass determined similarly as in Figure 3F (n = 4). (E) Mitotracker Red CMXRos mean
fluorescence intensity was measured by flow cytometry (n = 4). (F) Metabolic parameters including
glycolysis, citrate synthase activity, and oxidative phosphorylation (OPXHOS) was detected similarly as
in Figure 6C (n = 2 for ECAR and OCR, n = 3 for citrate synthase (CS) activity). * p < 0.05, ** p < 0.01,
*** p < 0.001.
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2.6. PARP Inhibition Restores NAD+ Level and SIRTUIN Expression
NAD+ and NADH plays a central role in redox homeostasis and cellular metabolism including
glycolysis via glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity [78] and OXPHOS
by regulating the transfer of electrons to complex I [79]. UVB irradiation caused a slight but
significant decrease in NAD+ level after both 20 and 40 mJ/cm2 UVB (Figure 7A). ABT-888 treatment
efficiently restored intracellular NAD+ content suggesting the role of PARP1 in UVB-mediated NAD+
depletion. It has been known that a decrease in NAD+ by enhanced PARP activation inhibits
another NAD+-consuming enzyme family, the class III histone deacetylase Sirtuins [33,34,36–38,80]
which regulate diverse cellular processes [81] including mitochondrial metabolism and have intricate
relationships with PARPs [82,83]. To test whether UVB modulate Sirtuin expression and PARPi can
restore their expression after UVB similarly as NAD+ level changes, we chose the 40 mJ/cm2 UVB
dose which caused a more significant increase in NAD+ level after ABT-888 treatment compared to
UVB-irradiated cells. We detected slight mRNA downregulation in SIRT1, SIRT2, SIRT3, SIRT4, SIRT5,
and SIRT7 after 40 mJ/cm2 UVB dose (Figure 7B) and PARP inhibition increased the gene expression of
all Sirtuins suggesting that intracellular NAD+ availability after UVB and PARPi may regulate SIRTs
expression. Although, the role of Sirtuins in the UVB-mediated cellular response and skin physiology
is poorly characterized [84–88], here we revealed the Sirtuin expression-modulatory effect of NAD+
after UVB and PARP inhibition. To explore the potential role of NAD+ and Sirtuins in supporting
glycolysis or oxidative phosphorylation further experiments are needed.
Cancers 2019, 11, x FOR PEER REVIEW 13 of 29 
 
2.6. PARP Inhibition Restores NAD+ Level and SIRTUIN Expression 
NAD+ and NADH plays a central role in redox homeostasis and cellular metabolism including 
glycolysis via glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity [78] and OXPHOS by 
regulating the transfer of electrons to complex I [79]. UVB irradiation caused a slight but significant 
decrease in NAD+ level after both 20 and 40 mJ/cm2 UVB (Figure 7A). ABT-888 treatment efficiently 
restored intracellular NAD+ content suggesting the role of PARP1 in UVB-mediated NAD+ depletion. 
It has been known that a decrease in NAD+ by enhanced PARP activation inhibits another NAD+-
consuming enzyme family, the class III histone deacetylase Sirtuins [33,34,36–38,80] which regulate 
diverse cellular processes [81] including mitochondrial metabolism and have intricate relationships 
with PARPs [82,83]. To test whether UVB modulate Sirtuin expression and PARPi can restore their 
expression after UVB similarly as NAD+ level changes, we chose the 40 mJ/cm2 UVB dose which 
caused a more significant increase in NAD+ level after ABT-888 treatment compared to UVB-
irradiated cells. We detected slight mRNA downregulation in SIRT1, SIRT2, SIRT3, SIRT4, SIRT5, and 
SIRT7 after 40 mJ/cm2 UVB dose (Figure 7B) and PARP inhibition increased the gene expression of all 
Sirtuins suggesting that intracellular NAD+ availability after UVB and PARPi may regulate SIRTs 
expression. Although, the role of Sirtuins in the UVB-mediated cellular response and skin physiology 
is poorly characterized [84–88], here we revealed the Sirtuin expression-modulatory effect of NAD+ 
after UVB and PARP inhibition. To explore the potential role of NAD+ and Sirtuins in supporting 
glycolysis or oxidative phosphorylation further experiments are needed. 
 
Figure 7. PARP inhibition restores NAD+ level and Sirtuin expression. (A) Total cellular NAD+ were 
quantified by colorimetric assay 24 h after UVB irradiation. Absorbance was measured at 490 nm (n 
= 2). (B) mRNA expression of the Sirtuin enzyme family 24 h post-UVB (40 mJ, n = 3). *; ** and *** 
indicate statistically significant difference at p < 0.05 and p < 0.01, p < 0.001, respectively. ## indicate 
significant difference at p < 0.01 compared to non-irradiated control. Error bars represent SEM. 
2.7. PARP Inhibition Enhances UVB-Mediated Upregulation of Metabolic Proteins 
To explore the potential mechanisms responsible for elevated oxidative phosphorylation after 
UVB and PARP inhibition, we checked the expression of metabolic proteins involved in oxidative 
phosphorylation by Western blot (Figure 8A,B). Consistent with their role in mitochondrial activity, 
we detected significant increase in ATM, p-ATM, SIRT1, peroxisome proliferator-activated receptor 
gamma coactivator 1-alpha (PGC1A), AMPK, p-AMPK, p53, p-p53, p-AKT, and p-p70S6K1 (mTOR 
activity) expression after UVB which was further enhanced by PARP inhibition. The most prominent 
and statistically significant upregulation in these proteins can be detected after 40 mJ/cm2 UVB dose 
similarly as OXPHOS was increased to two-fold at p < 0.001. PARPi induced statistically significant 
difference at 0 and 20 mJ/cm2 compared to vehicle control similarly as ABT-888 increased OXPHOS 
as well. PARP1 knockdown also induced upregulation in these proteins compared to siRNA control. 
Figure 7. PARP inhibition restores NAD+ level and Sirtuin expression. (A) Total cellular NAD+ were
quantified by colorimetric assay 24 h after UVB irradiation. Absorbance was measured at 490 nm
(n = 2). (B) mRNA expression of the Sirtuin enzyme family 24 h post-UVB (40 mJ, n = 3). *; ** and
*** indicate statistically significant difference at p < 0.05 and p < 0.01, p < 0.001, respectively. ## indicate
significant difference at p < 0.01 compared to non-irradiated control. Error bars represent SEM.
2.7. PARP Inhibition Enhances UVB-Mediated Upregulation of Metabolic Proteins
To explore the potential mechanisms responsible for elevated oxidative phosphorylation after
UVB and PARP inhibiti n, we checked the expression of metabolic proteins involved in oxidative
phosphorylation by Western blot (Figur 8A,B). Con istent with their role in mitochondrial activity,
we detected significant incr ase in ATM, p-ATM, SIRT1, p roxisome p oliferator-activated receptor
gamma coactivator 1-alpha (PGC1A), A PK, p-AMPK, p53, p-p53, p-AKT, and p-p70S6K1 (mTOR
activity) expression after UVB which was further enhanced by PARP inhibition. The most prominent
and statistically significant upregulation in these proteins an e detected after 40 mJ/c 2 UVB dose
similarly as OXPHOS was i creased to two-fold at p < 0.001. PARPi induced statistically significant
difference at 0 and 20 mJ/cm2 compared to vehic e control similarly as ABT-888 increased OXPHOS
as well. PARP1 knockdown also induced upregulation i these proteins compared to siRNA control.
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These results suggest that these proteins switch on oxidative metabolism and their elevated expression
may be responsible for higher oxygen consumption after UVB and ABT-888 treatment.
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proteins involved in oxidative phosphorylation were analyzed in total protein lysates. Protein of
interest were normalized to the loading control B-actin. Cells were harvested 24 h after UVB. Brightness
and contrast were adjusted. (B) Densitometric representation of Figure 8A proteins (n = min. 3). (C)
Protein expression involved in oxidative phosphorylation was confirmed by PARP1 knockdown. *; **
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2.8. PARP Inhibition and UVB-Induced Oxidative Phosphorylation and Autophagy Are Dependent on ATM,
AMPK, p53, AKT, and mTOR Activation
To test their requirement for increased oxidative phosphorylation, we applied KU-60019 as an
ATM inhibitor (Figure 9A) and ATM siRNA for gene silencing (Figure 10A), compound C as an
AMPK inhibitor, Pifithrin-alpha-HBr as a p53 inhibitor, Wortmannin as a phosphoinositide 3-kinase
(PI3Ki)/AKT inhibitor and Rapamycin as a mTOR inhibitor (Figure 9A). Chemical inhibition of these
proteins led to significant reduction in OXPHOS highlighting their role in mediating metabolic
alterations after UVB and PARP inhibition. ATM inhibition (Figure 9B) and ATM knockdown
(Figure 10B) also decreased the phosphorylation of AMPK, p53, AKT, and p70S6K1 which suggest
that elevation in OXPHOS after UVB is downstream of ATM, which is known as one of the most
important players in DNA damage response besides PARP1. Since CPD removal is mediated by
the energetically demanding nucleotide excision repair, keratinocytes may try to compensate their
increased DNA damage with a more intense mitochondrial activity to facilitate CPD elimination.
In this respect, OXPHOS seems to be a beneficial response after UVB. To confirm this hypothesis,
we applied inhibitors that decreased (ATMi, AMPKi, p53i, PI3Ki, mTORi) or limit the activity of
mitochondrial electron transport chain (oligomycin and rotenone) or inhibits mitochondrial protein
synthesis (chloramphenicol) (Figure 9C). Our data show that all these inhibitions led to a more
pronounced cell death after UVB which confirms that increased mitochondrial activity bears an
adaptive and antiapoptotic response after UVB. We also wanted to explore if UVB and PARPi-triggered
general autophagy (Figure 5A,B) by recycling damaged organelles and macromolecules serves to
provide metabolites for OXPHOS. To confirm this hypothesis, we tested the ATM, AMPK, p53, PI3K,
and mTOR inhibitors after 40 mJ/cm2 UVB that caused the most prominent decrease in oxygen
consumption (Figure 9A). Chemical inhibition of these proteins induced significant reduction in
LC3B (Figure 9D) and Parkin (Figure 9E) expression similarly as UVB and PARPi-induced OXPHOS
decreased after ATM, AMPK, p53, PI3K, and mTOR inhibitors indicating a parallel reduction in
oxidative phosphorylation, autophagy, and PARKIN expression (a marker for mitophagy) as well.
Reduction in PARKIN expression suggests impaired mitochondrial quality control, allowing the
accumulation of damaged mitochondria, corrupting mitochondrial function, eventually leading to
decreased OXPHOS. These results together suggest that after UVB and ABT-888 treatment, AMPK, p53,
AKT, and mTOR are the main mediators of oxidative phosphorylation downstream of ATM kinase,
and autophagy by recycling damaged cellular parts after stress response may provide metabolites to
mitochondria and supports OXPHOS after UVB exposure and PARP inhibition.
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on ATM, AMPK, p53, KT, and mTOR activation. (A) To determine key proteins involved in mediating
mitochondrial changes ATMi (KU-60019), AMPKi (Compound C), p53i (Pifithrin-alpha-HBr), PI3Ki
(Wortmannin), and TORi (R pamycin) were added to th me ium and OCR was measured as in
Figure 6C (n = min.3). (B) ATM downstream signali g pathway was investigated by W ern blot
with the addi ion of its pharmacological inhibitors KU-60019 (n = 3). Brightness and contrast were
adjusted. (C) Cell viability was me sured by flow cytometry as in Figure 1E after 40 mJ/cm2 UVB
with oligomycin, rotenone, chloramphenicol, ATMi, AMPKi, p53i, PI3Ki, and mTORi (n = min. 4). To
determine the involvem nt of ATM, AMPK, p53, AKT, and mTOR in the regulation of (D) autophagy
and (E) PARKIN expression, we applied their respectiv pharmacological inhibitors after 40 mJ/cm2
UVB. (n = 4). *; ** and *** indicate statistically significan difference at p < 0.05 and p < 0.01, p < 0.001,
respectively Error bars represent SEM. ATM: ataxia-telangiectasia-muta d kinase, AMPK: adenosine
monophosphate-activated kinase, AKT: protein kinase B, mTOR: mamm lian target of rapamycin,
OCR: oxygen consumption rate.
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3. Discussion
In this study, we identified morphological and functional changes of mitochondria after UVB and
PARP inhibition. Early after UVB exposure, we detected PAR formation, reflecting PARP activity which
was completely suppressed by PARP inhibition. We showed that loss of PARylation caused defective
CPD repair compared to the UVB-irradiated cells suggesting impaired NER pathway as several
PARP1-intercating partners (DDB1, DDB2, ATM, RAD51, ALC1, XPC) [89–91] have been described so
far. Furthermore, PARP1 promotes the establishment of locally relaxed chromatin structure [92] to
enable the removal of damaged DNA parts. Therefore, it is logical to assume that PARP inhibition
renders chromatin to become compact, blocking not only replication, transcription but also the repair of
UVB-induced photoproducts suggesting the particular importance of PARP1 in mediating transcription
coupled nucleotide excision repair. Our results show a prolongation in G2/M phase of cell cycle after
PARPi as described earlier [93–95]. Inhibition of PARP1 was synergistic with UVB with respect to
G2/M accumulation characteristic of severe DNA damage after 20 mJ/cm2. G2/M accumulation can
also be attributed to PARP trapping, in which inactivated PARP1 remains bound to DNA stalling
replication, transcription leading to replicative stress and double-strand breaks [96,97] which make
PARP inhibitors cytotoxic in combination with DNA damaging agents [98,99]. If DNA damage cannot
be repaired, cells try to evade the accumulation of mutations by initiating apoptosis. Since apoptotic
response after UVB cannot be ameliorated by PARPi, we can exclude the possibility that UVB-triggered
cell death in our model system is PARP1-dependent, it may rather suggest that the accumulated and
unrepaired CPDs augments the apoptotic response after PARPi. Long-term survival of keratinocytes
revealed that the combined treatment of UVB and PARP inhibition severely reduced cell proliferation
even at the non-irradiated conditions possibly suggesting the role of trapped PARP1-DNA complexes
preventing cells division. We also detected that loss of PARylation decreased the frequency of mutations
in UVB-treated cells as evidenced by decreased number of colonies after ABT-888 treatment suggesting
that PARPi initiate apoptosis of cells with a high content of CPDs. Our results are in accordance
with the anti-cancer effect of diverse PARP inhibitors and provide experimental evidence for the
photosensitizing effect of PARP inhibitors experienced clinically [100,101]. Nevertheless, it is important
to know that therapeutic application of PARP inhibitors might be associated with photosensitivity
(sunburn) but not with an increased photocarcinogenesis risk.
Emerging evidence suggest that autophagy induction can be coupled to DNA damage response [67].
Accordingly, UVB triggered the accumulation of autophagosomes which corroborates with enhanced
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LC3B expression. PARP inhibition resulted in enhanced autophagosome formation and higher LC3B
protein level. The role of PARP1 in the regulation of autophagy is still poorly understood, both
autophagy inducer [70] and inhibitory effect of PARP1 [75] can be found in the literature. In our model
system, increased autophagosome formation after UVB and PARPi can be attributed to the elevated
level of DNA damage (higher CPD content), which serves as a positive signal for autophagy since the
initiation of global genome NER (GG-NER) subpathway is controlled by autophagy [67,68].
As Le Brace et al. [28] demonstrated, different DNA damaging agents including UVC which also
induce CPD formation as UVB, led to AMPK activation and increased fatty acid oxidation. Similarly to
their results, UVB radiation triggered mitochondrial fusion and induced mitochondrial biogenesis,
which culminated in enhanced mitochondrial activity and complex metabolic events which were
more prominent in PARP-inhibited cells. Increased number of mitochondria and mitochondrial area
after UVB irradiation was more robust after PARPi. mRNA expression of mitochondrial biogenesis
regulators, increased MTCO1/SDHA ratio, higher mitochondrial mass show similar trends suggesting
that elevated mitochondrial content is indeed due to enhanced mitochondrial biogenesis and not
defective mitochondrial turnover. By measuring mitochondrial function, we observed that PARP
inhibition enhanced the UVB-mediated mitochondrial hyperpolarization, raised cellular ATP level
and OXPHOS. Interestingly, we detected neither mitochondrial membrane depolarization nor ATP
loss which normally occurs after PARP activation via NAD+ resynthesis from ATP [102]. Since
intracellular ATP concentration is also a regulator in DNA repair and a key factor in the cell’s decision
to die via apoptosis or necrosis [103], it is likely that this elevation in ATP level is required for
the energetically costly nucleotide excision repair to remove UVB-induced photoproducts, and/or
necessary for the apoptotic process as seen after staurosporine treatment [104]. Boost in mitochondrial
OXPHOS was dependent on ATM, AMPK, p53, AKT, and mTOR phosphorylation since inhibition
of them lead to significant reduction in oxygen consumption after both UVB and PARPi. Moreover,
enhanced mitochondrial activity seems to induce a beneficial response after DNA damage, since
decreasing mitochondrial biogenesis or ameliorating OXPHOS resulted in elevated cell death after
UVB irradiation suggesting the protective effect of OXPHOS on cell viability. Inhibition of the ATM,
AMPK, p53, PI3K, and mTOR pathways caused significant reduction in LC3A/B and Parkin expression
emphasizing their role in autophagy and mitophagy. Decrease in mitophagy and the concomitant
impaired mitochondrial quality control may also be an underlying cause for decreased OXPHOS after
chemical inhibition of these proteins. We hypothesize that the purpose of autophagy induction after
UVB-induced DNA damage is to recycle damaged molecules by fueling mitochondria with metabolites
for oxidative phosphorylation as suspected by Dong et al. [105] and autophagy promotes the DNA
damage recognition via NER. Since autophagy is an ATP-dependent process and cells must maintain
their energy status to promote autophagy, we cannot exclude reciprocal regulation that is the shift
toward oxidative metabolism regulates autophagy as described by Thomas et al. [106]. Nonetheless,
in our model system it seems obvious that the purpose of autophagy and OXPHOS induction is to
promote cell survival after UVB via ATM, AMPK, p53, AKT, and mTOR activation.
So how, increased mitochondrial activity is connected to DNA damage? The UVB-induced
photolesions trigger local conformational changes on DNA similarly as seen after etoposide
treatment [107] and UVC irradiation [108] which also resulted in increased mitochondrial biogenesis and
activity [18,28]. Since, PARP-inhibited cells displayed higher level of CPDs compared to UVB-irradiated
samples, it seems plausible that CPDs generated on DNA may be a trigger for mitochondrial changes.
This is supported by the fact that the phosphorylation status of the main DNA damage responders
(ATM, AMPK, p53, AKT, and mTOR) that are activated by UVB become more prominent after PARPi.
ATM is mainly activated by DNA double-strand breaks but also a sensor of CPDs [109]. Furthermore,
unrepaired CPD lesions in PARPi cells due to PARP trapping may eventually be converted into
DNA breaks during replication which is an ultimate trigger for ATM activation. ATM can directly
phosphorylate AMPK [110], p53 [111], and AKT [112] and via AKT and AMPK signaling ATM regulates
mTOR activity [113], as well to turn on oxidative metabolism. AMPK can also phosphorylate p53 at
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S15 [114], thereby potentiating its activity in enhancing mitochondrial metabolism. Furthermore, it is
noteworthy that although cell type-dependently, AMPK [115], p53 [116] AKT [117], and mTOR [118]
activation can trigger mitochondrial fusion which may also be a possible explanation for enhanced
mitochondrial activity. Since PARP inhibition alone do not induce CPD formation, we must take into
account that the PARPi-mediated changes in the non-irradiated cells are mediated by CPD-independent
mechanisms either through autophagy induction and/or NAD+ prevention. However, we can exclude
the involvement of NAD+ in the regulation of mitochondrial function after UVB, since morphological
alteration of mitochondria and oxidative phosphorylation do not show similar changes as intracellular
NAD+ availability after UVB irradiation.
4. Materials and Methods
4.1. Chemicals
All chemicals were obtained from Sigma-Aldrich (St. Louis, MO, USA) unless stated otherwise.
4.2. Cell Culture
Human immortalized keratinocyte-derived (HaCaT) cell line were cultured in a T75 flask, as
previously described [119] using 4500 mg/L Dulbecco’s modified eagle media (DMEM) Glutamax
supplement (Thermo Fisher Scientific, Waltham, MA, USA) containing 10% heat-inactivated fetal
bovine serum (FBS) and 0.5% antibiotic/antimycotic solution. For HPRT mutation assay, Chinese
hamster ovary (CHO) cells were used as described in Section 4.7. Cells were maintained in a humidified
incubator at 37 ◦C with 5% CO2 atmosphere.
4.3. Cell Treatment
Cells were harvested with trypsin-EDTA (Biosera, Budapest, Hungary) then seeded in 12-well
plate in 200,000 cell/well density (unless stated otherwise), and allowed to adhere for at least 12 h.
At 80% confluence, cells were pretreated with the PARP inhibitor veliparib (ABT-888) (Selleckchem,
Houston, TX, USA) at a final concentration of 25 µM. For detection of cell death, autophagy, mitophagy,
and OXPHOS, the following inhibitors were used: ATMi: 6 µM KU-60019 (Adooq, Irvine, CA, USA),
AMPKi: 2.5 µM compound C (Selleckchem), p53i: 30 µM pifithrin-alpha-HBr (AdooQ), mTORi:
300 nM rapamycin (AdooQ), PI3Ki: 300 nM wortmannin (AdooQ), mitochondrial activity inhibitors:
5 µM oligomycin, and 500 nM rotenone. To inhibit mitochondrial protein synthesis and hamper
mitochondrial function chloramphenicol (AdooQ) (25 µM) was used. For UVB irradiation, cells were
covered with 400 µl pre-warmed Dulbecco’s phosphate-buffered saline (DPBS) (Lonza, Walkersville,
MD, USA) and were subjected to 20 or 40 mJ/cm2 UVB using two UVB broadband tubes (TL-20W/12
RS; Philips, Eindhoven, The Netherlands). Immediately after irradiation, the old medium was placed
back on the cells to evade metabolic perturbations and cells were further cultured for 24 h. Controls
were covered with tin foil during irradiation. The proper UV dose was measured with a UVX digital
radiometer (UVP Inc., San Gabriel, CA, USA). Detached, dead cells were excluded from the experiments
except for cell viability.
4.4. Gene Silencing
On-target plus SMARTpool PARP1 and ATM siRNA sequence was purchased from Dharmacon
Research, Inc. (Lafayette, CO). Non-targeting siRNA (Dharmacon) was used as a control. HaCaT
cells were seeded into 12-well plates in complete high-glucose DMEM containing 10% FBS without
antibiotics. DharmaFECT transfection reagent (Dharmacon) in tube 1 and siRNA in 1 × siRNA buffer
(Dharmacon) in tube 2 was diluted in serum and antibiotics-free DMEM and incubated at room
temperature for 5 min. The two mixtures were combined and incubated further for 20 min and added
to the cells at a final siRNA concentration of 50 nM. After 48 h, cells were washed with DPBS, irradiated
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with UVB, and the medium was replaced with a complete growth medium. Silencing efficiency was
determined by Western blotting 24 h post-UVB.
4.5. Cell Viability and Proliferation
Over the 24 h period following UVB exposure cell viability was determined by dead cell apoptosis
kit containing propidium iodide/Alexa Fluor 488-conjugated Annexin V (Invitrogen, Carlsbad, CA,
USA) according to the manufacturer’s instruction. Labelled cells were analyzed by flow cytometry
with a FACSCalibur (Becton Dickinson, San Jose, CA, USA) measuring the fluorescence emission in
FL1 (530 nm) and FL3 (>575 nm). Double negative cells represent viable cells. For data collection
and evaluation CellQuest software 5.2 (Becton Dickinson) and Flowjo single cell analysis software
were used.
Cell proliferation was determined by clonogenic assay. Cells were seeded in 100 mm Petri dish at
5000 cells/dish and were allowed to grow for 10 days. The medium was replaced each day to monitor
the long-term effect of cell treatments. Ten days later, cells were washed with PBS, fixed with 100%
methanol, and stained with May-Grünwald-Giemsa solution (Histolab Products, Västra Frölunda,
Sweden).
4.6. Cell Cycle Analysis
Cell cycle progression was quantified using propidium iodide (PI) staining. Briefly, cells were
trypsinized, fixed with ice-cold 96% ethanol for 10 min, washed twice with PBS, and permeabilized
with 0.1% Triton X-100. After extensive washing, cells were incubated in PBS solution containing
0.5 mg/mL RNase at 37 ◦C for 1 h and counted for cell number normalization. For cell staining, PI was
used a final concentration of 20 µg/mL. Unbound PI was eliminated by washing with PBS and doublet
discrimination was performed. To determine DNA content samples were analyzed on the x-axis in
FL2-A channel using a FACSCalibur flow cytometer.
4.7. HPRT Mutation Assay
CHO cells were cultured in a HAT (hypoxanthine–aminopterin–thymidine) medium in T75 flask
for one week to remove cells with pre-existing HPRT mutation. After a week, HAT medium was
replaced with complete DMEM and cells were allowed to recover for three days. Thereafter, CHO
cells were seeded into a 6-well plate and allowed to adhere for 24 h. Next day, cells were cultured
with or without 25 µM ABT-888 and UVB irradiation was carried out with 10 or 20 mJ/cm2 dose. CHO
cells were cultured further for one week in DMEM with sub-culturing three times a week. After a
week, cells were trypsinized, counted, distributed to 100 mm Petri dish at concentration of 5 × 104 per
Petri dish in selection medium supplemented with 5 µg/mL 6-thioguanine (6-TG), and incubated for
10 days. After 10 days, cells were washed with PBS, fixed with 100% methanol for 10 min, and stained
with May-Grünwald-Giemsa solution. Mutant colonies were counted.
4.8. CPD-Specific Enzyme-Linked Immunosorbent Assay (ELISA)
Genomic DNA was extracted from HaCaT cells using a Purelink Genomic DNA mini kit (Thermo
Fisher Scientific) according to the manufacturer’s instruction. For quantitative detection of CPDs,
direct ELISA was applied as previously described [120].
4.9. Real-Time Quantitative RT-PCR
Total RNA was isolated using guanidinium isothiocyanate-phenol-chloroform extraction (TRI
reagent) (MRC, Cincinnati, OH, USA) according to the protocol by Chomczynski et al. [121]. RNA
concentration and purity were determined spectrophotometrically. RNA was deprived of DNA
contamination by DNase I treatment (Fermentas, St. Leon-Rot, Germany). Reverse transcription (RT)
was carried out using the high-capacity cDNA reverse transcription kit (Applied Biosystems, Foster
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City, CA, USA) according to the manufacturer’s instruction. Real-time RT-PCR analysis was performed
by the SYBR green method using a Lightcyler 480 II (Roche Diagnostics). Reactions were carried out in
384-well optical plates. RNA expression values were determined by 1.8−∆CT method and normalized
for the housekeeping gene SDHA and phosphoglycerate kinase 1 (PGK1) [122]. Primer pairs and
corresponding sequences are listed in Supplementary Table S1 “Primer pairs used in the study”.
4.10. Western Blot
HaCaT cells were pelleted by mild centrifugation at 1500 rpm for 5 min at 4 ◦C. The pellets were
lysed on ice with RIPA buffer supplemented with a protease inhibitor cocktail in 1:1000. After 5 min
incubation on ice, supernatants were obtained by centrifugation of the lysates at 15,000 rpm for 10 min at
4 ◦C. The concentration of proteins was determined using Pierce BCA assay kit (Thermo Fisher Scientific).
The lysates were mixed with 5X loading buffer (Bromophenol blue (0.25%), β-Mercaptoethanol (5%),
Glycerol (50%), SDS (sodium dodecyl sulfate; 10%), Tris-HCl (0.25 M, pH 6.8)), boiled for 10 min at
100 ◦C and subjected to 7.5%, 10%, or 12.5% SDS polyacrylamide gel electrophoresis. Proteins were
transferred onto nitrocellulose membrane (Bio-Rad, Hercules, CA, USA). The membranes were blocked
in TBST (0.05% Tween 20 in TBS buffer) containing 5% bovine serum albumin (BSA). The incubation with
primary antibodies was carried out overnight at 4 ◦C followed by washing. Horseradish peroxidase
(HRP)-conjugated goat anti-mouse or anti-rabbit IgG was used as a secondary antibody (Bio-Rad) at
room temperature for 1 h. Proteins were visualized by ECL Prime Western blotting detection reagent
(Thermo Fisher Scientific). All the antibodies used for Western blotting were listed in Supplementary
Table S2 “Primer antibodies used in the study”. Bands were quantified using the ImageJ open source
software [123] (version 1.51k, National Institutes of Health, Bethesda, MD). Proteins of interest were
normalized for β-actin. Sample uncut blots are provided on Supplementary Figure S2.
4.11. Mitochondrial Mass
24 h post-UVB, Mitotracker Green (Thermo Fisher Scientific) were added to the culture medium
at a final concentration of 100 nM and cells were incubated at 37 ◦C for 30 min. Following incubation,
cells were washed with PBS and harvested by trypsinization and then placed on ice. The fluorescence
intensity of cells stained with Mitotracker Green was analyzed in a FL1 channel using flow cytometry.
4.12. Determination of Mitochondrial Membrane Potential
HaCaT cells were seeded in a culture plate and next day subjected to UVB. 24 h post-UVB,
3,3′-dihexyloxacarbocyanine iodide (DiOC6(3)) (Invitrogen) were added to the culture medium at a
final concentration of 40 nM and cells were further incubated at 37 ◦C for 30 min. Following incubation,
cells were washed with PBS and harvested by trypsinization and then placed on ice. The fluorescence
intensity of cells stained with DiOC6(3) was analyzed in FL1 channel using flow cytometry.
4.13. Determination of Mitochondrial Ultrastructure, Mitochondrial Number, and Area by Transmission
Electron Microscopy (TEM)
After cell treatment, cells were washed with DPBS, harvested by trypsinization, pelleted, and fixed
by 3% glutaraldehyde (EMS, Hatfield, PA, USA) in 0.1 M cacodylic acid (EMS) buffer complemented
by 5% sacharose for 2 h. After washing steps in 0.1 M cacodylic acid buffer, cells were osmificated
in 1% OsO4, dehydrated in ascending alcohol row, namely 50% for 2 × 10’, 70% for 2 × 10’, 96% for
2 × 15’, absolute ethanol for 3 × 20’, and propylene oxide for 2 × 10’. Then, overnight a durcupan
araldite treatment was used for embedding the samples. Encapsulation occurred in an incubator for
48 h and ultrathin section was made by Leica EM UC7 ultramicrotome (Leica Microsystems, GmbH,
Wetzlar, Germany). Standard contrasting was performed by uranyl acetate (EMS) and Reynolds’ lead
citrate solution. High resolution TEM images was made by the Jeol JEM 1010 electron microscope and
software (JEOL Inc. Peabody, MA, USA).
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4.14. Assessment of Mitochondrial Morphology and Autophagy by Confocal Microscopy
Cells were plated on glass slides in a 24-well plate and 24 h post-UVB cells were stained with
100 nM Mitotracker Red CMXRos (Thermo Fisher Scientific) dye at 37 ◦C for 30 min. Cells were
washed with PBS, fixed with 3.7% paraformaldehyde solution at room temperature for 10 min and
permeabilized with 0.2% Triton X-100 for 10 min. After washing with PBS, blocking was performed by
1% BSA-containing PBS at 37 ◦C for 1 h. Cells were incubated with an Alexa Fluor 488-conjugated
LC3A/B antibody diluted in 1% BSA (1:50) at 4 ◦C overnight in a humid chamber. Next day, slides were
washed three times with PBS. Prior to imaging, cells were stained with a mounting medium with DAPI
and analyzed by confocal microscopy using 60x oil immersion objective. Background subtraction, noise
reduction, local contrast enhancement, unsharp mask, and bandpass filtering were applied on raw
images for better image quality and proper image evaluation [124]. Processed images were analyzed
by ImageJ software. Mitochondrial complexity was calculated from confocal microscopic images and
was defined as a form factor ((Perimeter2/(4pi*area)). For flow cytometric analysis of autophagy, cells
were washed with PBS and harvested by trypsinization. Fixation, permeabilization, and blocking
were carried out as described above. Cells were incubated with Alexa Fluor 488-conjugated LC3A/B
antibody using 1:500 dilution at 4 ◦C overnight. Next day, after extensive washing, cells were analyzed
for Alexa-488 fluorescence intensity in FL1 channel by flow cytometry.
4.15. Measurement of Citrate Synthase Activity
For determination of citrate synthase activity, a citrate synthase assay kit was used according to
the manufacturer’s instruction. Optical density changes by kinetic program was determined at 412 nm
using microplate reader. Values were normalized to total protein concentration.
4.16. Analysis of Oxygen Consumption and Extracellular Acidification
Oxygen consumption (OCR) and extracellular acidification rate (ECAR) was measured using an
XF96 extracellular flux analyzer (Seahorse Bioscience, North Billerica, MA, USA). The rate of oxygen
consumption indicates oxidative phosphorylation, whereas ECAR represent lactic acid formed during
glycolysis. Cells were seeded in a XF96 cell culture plate at 10,000 cell/well density. One hour prior to
the assay, culture medium was replaced with unbuffered DMEM (Seahorse Bioscience) supplemented
with 10 mM glucose and then cells were equilibrated in a CO2-free incubator for 1 h. After four
measurements of oxygen consumption, oligomycin and antimycin A were subsequently injected to
determine mitochondria-linked ATP production and basal OCR, respectively. All OCR and ECAR
values were normalized to the total protein obtained from cells lysed by 1 M NaOH.
4.17. Determination of NAD+ Level
The colorimetric assay for NAD+/NADH ratio determination was purchased from Biovision
(Mountain View, CA, USA). Cells were washed with PBS two times and harvested by a trypsin-EDTA
solution and pelleted by mild centrifugation. The pellet was extracted with NAD+ or NADH extraction
buffer and exposed to freeze/thaw cycles. Samples were spun and the supernatant was transferred to a
96-well plate for NAD+/NADH assays. For NAD+ determination, half of the samples were transferred
into another tube and NAD+ was decomposed by heating samples at 60 ◦C. Finally, working reagent
was added to the samples, and optical density was determined at 450 nm. Optical density of the
standard curve and samples was used to calculate NAD+ content. Values were normalized to total
protein concentration.
4.18. Measurement of ATP Content
For determination of ATP level, an ATP colorimetric/fluorometric assay purchased from Biovision
was used according to the manufacturer. Optical density was determined at 570 nm using a microplate
reader. Values were normalized to total protein concentration.
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4.19. Statistical Analysis
Statistical analysis was carried out by the Kolmogorov–Smirnov test to assess the normality of the
population. The frequency of mitochondrial morphological subtypes (fragmented, intermediate, and
tubular) was calculated by chi2 and Ficher’s exact test. To assess the statistical significance between
untreated and differently treated groups, ANOVA complemented by Dunnett’s post-hoc test was used.
The comparison of two groups was applied by an independent t-test. All data are reported as mean ±
SEM. A p < 0.05 was considered statistically significant. Statistical significance was determined by
the GraphPad Prism 7 (GraphPad Software Inc., San Diego, CA, USA) and SPSS 25 software. (SPSS
package for Windows, Release 25.; SPSS, Chicago, IL, USA).
5. Conclusions
Our results provide new information about the role of ATM and PARP1 proteins in the regulation
of mitochondrial morphology and function after UVB irradiation. Moreover, it suggests that UVB
and PARPi-caused elevation of oxidative phosphorylation is mediated by the complex interplay of
metabolic sensors including ATM, AMPK, p53, AKT, and mTOR which are the main mediators that
connect DNA damage with oxidative metabolism and autophagy.
Data Availability: All primary data is uploaded to https://figshare.com/s/49fbcd8cfd5802ea15f9 (DOI:
10.6084/m9.figshare.8107727).
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Figure S1: Uncut PAR (10H) Western blot, Figure S2: Sample uncut blots, Table S1: Primer pairs used in the study,
Table S2: Primary antibodies used in the study.
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Abbreviations
CPD cyclobutane pyrimidine dimer
PAR poly (ADP-ribose) polymer
PARP1 poly (ADP-ribose) polymerase 1
ATM kinase ataxia-telangiectasia-mutated kinase
AMPK adenosine monophosphate-activated kinase
mTOR mammalian target of rapamycin
p70S6K1 ribosomal protein S6 kinase beta-1
HPRT hypoxanthine-guanine phosphoribosyltransferase
PGC1A peroxisome proliferator activated receptor gamma coactivator-1 alpha
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MTCO1 mitochondrially encoded cytochrome C oxidase I
CS citrate synthase
TCA tricarboxylic acid
SDHA succinate dehydrogenase complex, subunit A
PGK1 phosphoglycerate kinase 1
NRF2 nuclear respiratory factor 2
ERRA estrogen-related receptor alpha
Tfam mitochondrial transcription factor A
OCR oxygen consumption rate
ECAR extracellular acidification rate
OXPHOS oxidative phosphorylation
CHO Chinese hamster ovary
Mfn1 mitofusin 1
Mfn2 mitofusin 2
OPA1 optic atrophy 1
LC3A/B microtubule-associated proteins 1A/1B light chain 3B
GAPDH glyceraldehyde-3-phosphate dehydrogenase
PI3K phosphoinositide 3-kinase
DiOC6(3) 3,3′-dihexyloxacarbocyanine iodide
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